Stem Cell Clinics Are Advertising Their Treatments As Clinical Trials. They’re Not – Forbes
Forbes |
Stem Cell Clinics Are Advertising Their Treatments As Clinical Trials. They’re Not
Forbes In recent years, companies offering questionable stem cell therapies got the bright idea that they could describe their treatments as clinical trials, register them on ClinicalTrials.gov and thereby get some free advertising. Most stem cell treatments … Dozens of US clinics sell unproven stem cell therapies for heart failureReuters The curious case of ClinicalTrials.gov, where dubious stem cell therapies seem legitArs Technica Caveat Emptor for Heart Failure Patients Considering Stem Cell TxMedPage Today Healio –News-Medical.net –MinnPost all 12 news articles » |
Forbes |
Stem Cell Clinics Are Advertising Their Treatments As Clinical Trials. They’re Not
Forbes This wasn’t supposed to happen. Since 1997, the National Institutes of Health has maintained a database of clinical trials, ClinicalTrials.gov, that lists trials underway in the U.S. and throughout the world. It’s an invaluable resource, providing a … The curious case of ClinicalTrials.gov, where dubious stem cell therapies seem legitArs Technica Stem cell centers claim to offer effective heart failure therapy despite lack of FDA approvalNews-Medical.net ‘Stem cell centers’ often deliver therapy for HF without preevaluations, follow-upHealio MinnPost –MedPage Today all 12 news articles » |
Forbes |
Stem Cell Clinics Are Advertising Their Treatments As Clinical Trials. They’re Not
Forbes This wasn’t supposed to happen. Since 1997, the National Institutes of Health has maintained a database of clinical trials, ClinicalTrials.gov, that lists trials underway in the U.S. and throughout the world. It’s an invaluable resource, providing a … The curious case of ClinicalTrials.gov, where dubious stem cell therapies seem legitArs Technica Stem cell centers claim to offer effective heart failure therapy despite lack of FDA approvalNews-Medical.net ‘Stem cell centers’ often deliver therapy for HF without preevaluations, follow-upHealio MinnPost –MedPage Today all 12 news articles » |
Alphr |
What is CRISPR-Cas9?
Alphr CRISPR-Cas9 is a genome editing tool that’s able to “cut” DNA in a targeted fashion, allowing scientists to accurately edit the building blocks of life. You’ll likely see it mentioned alongside the slightly-less-famous duo of CRISPR-Cas1 and CRISPR … Crispr Theraptc (CRSP) CEO Sells $166380.25 in StockSports Perspectives Crispr Theraptc (NASDAQ:CRSP) Coverage Initiated at SunTrust Banks, Inc.Community Financial News Kurt Von Emster Sells 81435 Shares of CRISPR THERAPTC (NASDAQ:CRSP) StockStock Observer Chaffey Breeze –Breaking Finance News all 8 news articles » |